Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Substance-use disorders Pre-clinical and mechanistic studies A large body of pre-clinical and mechanistic literature is available regarding the putative effects of GLP-1RAs on substance misuse (Supplementary Section 5): 24 for alcohol 59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82 , 8 for opiates 63,83,84,85,86,87,88,89 , 16 for stimulants, including cocaine and amphetamines 90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105 , and 4 for nicotine 106,107,108,109
A meta-analysis of 28 trials found that Mounjaro tends to reduce body weight more than semaglutide, ranging from 11 lbs to 21 lbs with tirzepatide, compared to 6 lbs to 11 lbs for semaglutide
The analysis was conducted from the perspective of Chinese payers, and a lifetime horizon was used
Subsequent subregion analyses showed that the ventral tegmental area as well as subregions of the amygdala displayed enhanced activity patterns after GLP-1MK-801 treatment (Extended Data Fig
